Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: A0A3S7X8J5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 107 | 109 | PF00675 | 0.421 |
CLV_NRD_NRD_1 | 218 | 220 | PF00675 | 0.616 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.415 |
CLV_PCSK_KEX2_1 | 107 | 109 | PF00082 | 0.421 |
CLV_PCSK_KEX2_1 | 211 | 213 | PF00082 | 0.558 |
CLV_PCSK_KEX2_1 | 218 | 220 | PF00082 | 0.556 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.415 |
CLV_PCSK_KEX2_1 | 49 | 51 | PF00082 | 0.329 |
CLV_PCSK_PC1ET2_1 | 211 | 213 | PF00082 | 0.565 |
CLV_PCSK_PC1ET2_1 | 218 | 220 | PF00082 | 0.550 |
CLV_PCSK_PC1ET2_1 | 49 | 51 | PF00082 | 0.329 |
CLV_PCSK_SKI1_1 | 211 | 215 | PF00082 | 0.604 |
CLV_PCSK_SKI1_1 | 45 | 49 | PF00082 | 0.376 |
CLV_PCSK_SKI1_1 | 53 | 57 | PF00082 | 0.382 |
CLV_PCSK_SKI1_1 | 93 | 97 | PF00082 | 0.534 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.705 |
DEG_SCF_FBW7_1 | 224 | 231 | PF00400 | 0.439 |
DOC_CKS1_1 | 225 | 230 | PF01111 | 0.400 |
DOC_CYCLIN_yCln2_LP_2 | 186 | 192 | PF00134 | 0.408 |
DOC_MAPK_gen_1 | 197 | 205 | PF00069 | 0.427 |
DOC_MAPK_gen_1 | 3 | 9 | PF00069 | 0.669 |
DOC_MAPK_gen_1 | 48 | 58 | PF00069 | 0.544 |
DOC_MAPK_MEF2A_6 | 49 | 58 | PF00069 | 0.572 |
DOC_USP7_MATH_1 | 228 | 232 | PF00917 | 0.402 |
DOC_USP7_MATH_1 | 251 | 255 | PF00917 | 0.476 |
DOC_USP7_UBL2_3 | 44 | 48 | PF12436 | 0.534 |
DOC_USP7_UBL2_3 | 49 | 53 | PF12436 | 0.525 |
DOC_WW_Pin1_4 | 224 | 229 | PF00397 | 0.436 |
DOC_WW_Pin1_4 | 254 | 259 | PF00397 | 0.402 |
LIG_14-3-3_CanoR_1 | 120 | 126 | PF00244 | 0.617 |
LIG_14-3-3_CanoR_1 | 163 | 169 | PF00244 | 0.397 |
LIG_BIR_III_2 | 221 | 225 | PF00653 | 0.327 |
LIG_CSL_BTD_1 | 186 | 189 | PF09270 | 0.406 |
LIG_deltaCOP1_diTrp_1 | 184 | 190 | PF00928 | 0.490 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.585 |
LIG_FHA_1 | 259 | 265 | PF00498 | 0.371 |
LIG_FHA_2 | 41 | 47 | PF00498 | 0.573 |
LIG_LIR_Gen_1 | 135 | 143 | PF02991 | 0.300 |
LIG_LIR_Gen_1 | 66 | 75 | PF02991 | 0.526 |
LIG_LIR_Nem_3 | 135 | 139 | PF02991 | 0.309 |
LIG_LIR_Nem_3 | 66 | 72 | PF02991 | 0.530 |
LIG_PDZ_Class_2 | 261 | 266 | PF00595 | 0.372 |
LIG_SH2_CRK | 111 | 115 | PF00017 | 0.636 |
LIG_SH2_GRB2like | 111 | 114 | PF00017 | 0.620 |
LIG_SH2_STAP1 | 155 | 159 | PF00017 | 0.364 |
LIG_SH2_STAP1 | 168 | 172 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 150 | 153 | PF00017 | 0.404 |
LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.323 |
LIG_SH2_STAT5 | 226 | 229 | PF00017 | 0.445 |
LIG_SH3_3 | 222 | 228 | PF00018 | 0.385 |
LIG_SH3_3 | 242 | 248 | PF00018 | 0.470 |
LIG_SUMO_SIM_anti_2 | 201 | 207 | PF11976 | 0.434 |
LIG_WW_1 | 223 | 226 | PF00397 | 0.476 |
MOD_CK1_1 | 164 | 170 | PF00069 | 0.388 |
MOD_CK1_1 | 254 | 260 | PF00069 | 0.501 |
MOD_CK2_1 | 164 | 170 | PF00069 | 0.387 |
MOD_CMANNOS | 187 | 190 | PF00535 | 0.600 |
MOD_GlcNHglycan | 18 | 21 | PF01048 | 0.454 |
MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.647 |
MOD_GlcNHglycan | 253 | 256 | PF01048 | 0.712 |
MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.490 |
MOD_GSK3_1 | 224 | 231 | PF00069 | 0.434 |
MOD_GSK3_1 | 253 | 260 | PF00069 | 0.434 |
MOD_N-GLC_1 | 112 | 117 | PF02516 | 0.412 |
MOD_NEK2_1 | 114 | 119 | PF00069 | 0.599 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.627 |
MOD_NEK2_1 | 206 | 211 | PF00069 | 0.344 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.568 |
MOD_PKA_2 | 119 | 125 | PF00069 | 0.590 |
MOD_PKA_2 | 164 | 170 | PF00069 | 0.375 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.612 |
MOD_Plk_4 | 29 | 35 | PF00069 | 0.510 |
MOD_ProDKin_1 | 224 | 230 | PF00069 | 0.435 |
MOD_ProDKin_1 | 254 | 260 | PF00069 | 0.400 |
MOD_SUMO_for_1 | 95 | 98 | PF00179 | 0.678 |
TRG_DiLeu_BaEn_1 | 74 | 79 | PF01217 | 0.518 |
TRG_ENDOCYTIC_2 | 11 | 14 | PF00928 | 0.596 |
TRG_ENDOCYTIC_2 | 111 | 114 | PF00928 | 0.594 |
TRG_ER_diArg_1 | 106 | 108 | PF00400 | 0.627 |
TRG_ER_diArg_1 | 162 | 165 | PF00400 | 0.381 |
TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.621 |
TRG_NLS_MonoExtN_4 | 45 | 52 | PF00514 | 0.561 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILG9 | Leptomonas seymouri | 73% | 100% |
A0A0S4KRJ1 | Bodo saltans | 43% | 100% |
A0A1X0PA98 | Trypanosomatidae | 54% | 100% |
A0A422NVC0 | Trypanosoma rangeli | 54% | 100% |
A4HBD1 | Leishmania braziliensis | 84% | 100% |
A4IAH9 | Leishmania infantum | 100% | 100% |
C9ZLR0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
E9B5K3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4Q2D3 | Leishmania major | 93% | 100% |